No products in the cart.

Anti-USP13 antibody

SKU Product Brand Unit Availability Price 促销价 Quantity  
AB-07-2219
Anti-USP13 antibody
洱畔/Erpan Tech In stock

Specifications        

Product Cat#: AB-07-2219
Product type: Primary antibody
Antigen: USP13
Immunogen: The antiserum was produced against synthesized peptide derived from internal of human USP13.
Species immunized: Rabbit
Isotype: IgG
Applications: Western Blot (1:500-1:2500); ELISA (1:35000)
Reactivity: Human, Mouse
Clonality (clone number): Polyclonal
Form: Liquid
Buffer: Rabbit IgG in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.
Concentration: 1 mg/ml
Purity: Antigen affinity chromatography
Storage: Aliquot and freeze at -20°C. Avoid multiple freeze/thaw cycles.
Alternative names: Ubiquitin carboxyl-terminal hydrolase 13; EC 3.1.2.15; Ubiquitin thioesterase 13; Ubiquitin-specific-processing protease 13; Deubiquitinating enzyme 13; Isopeptidase T-3; ISOT-3; USP13; ISOT3
展开

靶标信息

Deubiquitinase that mediates deubiquitination of target proteins such as BECN1, MITF, SKP2 and USP10 and is involved in various processes such as autophagy and endoplasmic reticulum-associated degradation (ERAD). Component of a regulatory loop that controls autophagy and p53/TP53 levels: mediates deubiquitination of BECN1, a key regulator of autophagy, leading to stabilize the PIK3C3/VPS34-containing complexes. Also deubiquitinates USP10, an essential regulator of p53/TP53 stability. In turn, PIK3C3/VPS34-containing complexes regulate USP13 stability, suggesting the existence of a regulatory system by which PIK3C3/VPS34-containing complexes regulate p53/TP53 protein levels via USP10 and USP13. Recruited by nuclear UFD1 and mediates deubiquitination of SKP2, thereby regulating endoplasmic reticulum-associated degradation (ERAD). Also regulates ERAD through the deubiquitination of UBL4A a component of the BAG6/BAT3 complex. Mediates stabilization of SIAH2 independently of deubiquitinase activity: binds ubiquitinated SIAH2 and acts by impairing SIAH2 autoubiquitination. Has a weak deubiquitinase activity in vitro and preferentially cleaves ‘Lys-63’-linked polyubiquitin chains. In contrast to USP5, it is not able to mediate unanchored polyubiquitin disassembly. Able to cleave ISG15 in vitro; however, additional experiments are required to confirm such data.

产品来源

洱畔科技实验室

文件下载

MSDS-AB-07-2219.pdf (下载168 )